Inhibition of nitric oxide formation and superoxide generation during reduction of LY83583 by neuronal nitric oxide synthase

European Journal of Pharmacology

Volumn 360, Issue 2-3, 1998, Pages 213-218

  Kumagai, Yoshito ^a   Midorikawa, Kazumi ^a   Nakai, Yumi ^b   Yoshikawa, Toshikazu ^b   Kushida, Kazuki ^c   Homma Takeda, Shino ^a   Shimojo, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

cGMP; LY83583; Nitric oxide (NO) synthase; Quinone; Superoxide

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; CALCIUM CHLORIDE; CALMODULIN; CYCLIC GMP; CYTOCHROME P450 REDUCTASE; LYASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ANIMAL TISSUE; ARTICLE; CEREBELLUM; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; SUPERNATANT;

AMINOQUINOLINES; ANIMALS; ENZYME INHIBITORS; FLAVOPROTEINS; MALE; NAD(P)H DEHYDROGENASE (QUINONE); NADH, NADPH OXIDOREDUCTASES; NADP; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 0032491384     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00666-9     Document Type: Article

References (36)

1. Barbier A.J.M., Lefebvre R.A. Effect of LY83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur. J. Pharmacol. 219:1992;331-334.
2. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
3. Bradford M.M. A rapid and sensitive method for the quantitation of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
5. Cherry P.D., Omar H.A., Farrell K.A., Stuart J.S., Wolin M.S. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am. J. Physiol. 259:1990;H1056-1062.
6. Chesis P.L., Levin D.E., Smith M.T., Ernster L., Ames B.N. Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA. 81:1984;1696-1700.
7. Diamond J., Chu E. A novel cyclic GMP-lowering agent, LY83583, blocks carbachol-induced cyclic GMP elevation and in rabbit atrial strips without blocking the negative inotropic effect of carbachol. Can. J. Physiol. Pharmacol. 63:1985;908-911.
8. Dierks E.A., Burstyn J.N. Nitric oxide (NO·), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem. Pharmacol. 51:1996;1593-1600.
9. Furchgott R.F. The role of the endothelium in the response of vascular smooth muscle to drug. Annu. Rev. Pharmacol. Toxicol. 24:1984;175-197.
10. Furchgott R.F., Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels. 28:1991;52-61.
11. Gidari A.S., Furchgott F.R., Jothianandan D. Inhibition by LY83583 of endothelium-dependent relaxation of rabbit aorta. FASEB J. 3:1989;A1178.
12. 2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-sepharose affinity chromatography. Biochem. Biophys. Res. Commun. 104:1982;830-836.
13. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Rad. Res. Commun. 18:1993;195-199.
14. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65:1989;1-21.
15. Iyanagi T. On the mechanisms of one- and two-electron transfer by flavin enzymes. Chemica Scripta. 27A:1987;31-36.
16. Kontos H.A., Enoch P. Hydroxyl radical-dependent inactivation of guanylate cyclase in cerebral arterioles by methylene blue and by LY83583. Stroke. 24:1993;427-434.
17. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J. Biol. Chem. 267:1992;11374-11378.
18. Kumagai Y., Lin L.Y., Hiratsuka A., Narimatsu S., Suzuki T., Yamada H., Oguri K., Yoshimura Y., Cho A.K. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxy-methamphetamine enantiomers by rats. Mol. Pharmacol. 45:1994;359-365.
19. Kumagai Y., Shinyashiki M., Sun G.F., Shimojo N., Sagai M. An efficient method for purification of cuprozinc superoxide dismutase from bovine erythrocytes. Experientia. 50:1994;673-676.
20. Kumagai Y., Arimoto T., Shinyashiki M., Shimojo N., Nakai Y., Yoshikawa T., Sagai M. Generation of reactive oxygen species during interaction of diesel exhaust particle components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage. Free Rad. Biol. Med. 22:1997;479-487.
21. Kumagai Y., Nakajima H., Midorikawa K., Homma-Takeda S., Shimojo N. The inhibition of nitric oxide formation by neuronal nitric oxide synthase by quinones: nitric oxide synthase as a quinone reductase. Chem. Res. Toxicol. 6:1998;608-613.
22. Lowenstein C.J., Snyder S.H. Nitric oxide, a novel biologic messenger. Cell. 70:1992;705-707.
23. Luo D., Vincent S.R. Inhibition of nitric oxide synthase by antineoplastic anthracyclines. Biochem. Pharmacol. 47:1994;2111-2112.
24. Luo D., Das S., Vincent S.R. Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur. J. Pharmacol. 290:1995;247-251.
25. MacLeod K.M., Ng D.D.W., Harris K.H., Diamond J. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to α-adrenoceptor stimulation. Mol. Pharmacol. 32:1987;59-64.
26. Monks T.J., Hanzlik R.P., Cohen G.M., Ross D., Graham D.G. Quinone Chemistry and toxicology. Toxicol. Appl. Pharmacol. 112:1992;2-16.
27. Mülsch A., Busse R., Liebau S., Förstermann U. LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247:1988;283-288.
28. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 80:1991;1-41.
29. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
30. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267:1992;24173-24176.
31. Schmidt M.J., Sawyer B.D., Truex L.L., Marshall W.S., Fleisch J.H. LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther. 232:1985;764-769.
32. Schmidt H.H.H.W., Pollock J.S., Nakane M., Gorsky L.D., Förstermann U., Murad F. Purification of a soluble isoform of guanylyl cyclase- activating factor synthase. Proc. Natl. Acad. Sci. USA. 88:1991;365-369.
33. Støen R., Brubakk A.M., Vik T., Lossius K., Jynge P., Karlsson J.O.G. Postnatal changes in mechanisms mediating acetylcholine-induced relaxation in piglet femoral arteries. Pediatr. Res. 41:1997;702-707.
34. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., Nathan C.F. Inhibition of macrophase and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5:1991;98-103.
35. Sundqvist T., Axelsson K.L. The cGMP modulator, LY83583 alters oxygen metabolites differently in cultured endothelial cells and isolated neutrophilic granulocytes. Pharmacol. Toxicol. 72:1993;169-174.
36. Wakabayashi I., Sakamoto K., Hatake K. Inhibitory effect of aclarubicin on endothelium-dependent relaxation of rat aorta. Pharmacol. Toxicol. 68:1991;187-191.